Skip to main content
Top
Published in: International Journal of Hematology 5/2017

01-11-2017 | Case Report

Congenital immature pure erythroid leukemia with E-cadherin expression

Authors: Akihiro Tamura, Suguru Uemura, Atsuro Saito, Saki Okubo, Nanako Nino, Teppei Tahara, Takehito Yokoi, Kenji Kishimoto, Toshiaki Ishida, Daiichiro Hasegawa, Keiichiro Kawasaki, Seiji Yoshimoto, Hideto Nakao, Makiko Yoshida, Yoshiyuki Kosaka

Published in: International Journal of Hematology | Issue 5/2017

Login to get access

Abstract

Congenital pure erythroid leukemia is exceedingly rare and poses a diagnostic challenge. We report an atypical case of congenital pure erythroid leukemia that did not express typical erythroid markers. The patient presented with a high white blood cell count with blastic cells at birth. Although flow cytometric analyses of peripheral blood and bone marrow showed a large CD45-negative cell population, we did not identify any evidence of monoclonality. While the circulating blasts decreased with only supportive care, hepatomegaly with multiple nodules was accompanied by liver failure, disseminated intravascular coagulation, and development of hemophagocytic lymphohistiocytosis. Pathological examination of the liver biopsy specimen revealed a small round cell tumor that was negative for nearly all hematopoietic cell markers, including classical erythroid cell markers, and positive for CD43, CD71, and E-cadherin, an early erythroid marker epithelial calcium-dependent adhesion protein, suggesting that these tumor cells originated from an immature erythroblast. We found high β-catenin and c-Myc protein expression, which were not previously described in pure erythroid leukemia. Cytosine arabinoside temporarily alleviated clinical symptoms; however, the patient died of progressive disease at 8 months of age. This case indicates that E-cadherin is useful for diagnosing pure erythroid leukemia, even in immature cases.
Literature
1.
go back to reference Bresters D, Reus AC, Veerman AJ, van Wering ER, van der Does-van den Berg A, et al. Congenital leukemia: the Dutch experience and review of the literature. Br J Haematol. 2002;117:513–24.CrossRefPubMed Bresters D, Reus AC, Veerman AJ, van Wering ER, van der Does-van den Berg A, et al. Congenital leukemia: the Dutch experience and review of the literature. Br J Haematol. 2002;117:513–24.CrossRefPubMed
2.
go back to reference Sande JE, Arceci RJ, Lampkin BC. Congenital and neonatal leukemia. Semin Perinatol. 1999;23:274–5.CrossRefPubMed Sande JE, Arceci RJ, Lampkin BC. Congenital and neonatal leukemia. Semin Perinatol. 1999;23:274–5.CrossRefPubMed
3.
go back to reference Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.CrossRefPubMed Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.CrossRefPubMed
4.
go back to reference Liu W, Hasserjian RP, Hu Y, Zhang L, Miranda RN, Medeiros LJ, et al. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification. Mod Pathol. 2011;24:375–83.CrossRefPubMed Liu W, Hasserjian RP, Hu Y, Zhang L, Miranda RN, Medeiros LJ, et al. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification. Mod Pathol. 2011;24:375–83.CrossRefPubMed
5.
go back to reference Zuo Z, Polski JM, Kasyan A, Medeiros LJ. Acute erythroid leukemia. Arch Pathol Lab Med. 2010;134:1261–70.PubMed Zuo Z, Polski JM, Kasyan A, Medeiros LJ. Acute erythroid leukemia. Arch Pathol Lab Med. 2010;134:1261–70.PubMed
6.
go back to reference Ohgami RS, Chisholm KM, Ma L, Arber DA. E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms. Am J Clin Pathol. 2014;141:656–64.CrossRefPubMed Ohgami RS, Chisholm KM, Ma L, Arber DA. E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms. Am J Clin Pathol. 2014;141:656–64.CrossRefPubMed
7.
go back to reference Vodyanik MA, Thomson JA, Slukvin II. Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood. 2006;108:2095–105.CrossRefPubMedPubMedCentral Vodyanik MA, Thomson JA, Slukvin II. Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood. 2006;108:2095–105.CrossRefPubMedPubMedCentral
8.
go back to reference Dahlke MH, Larsen SR, Rasko JE, Schlitt HJ. The biology of CD45 and its use as a therapeutic target. Leuk Lymphoma. 2004;45:229–36.CrossRefPubMed Dahlke MH, Larsen SR, Rasko JE, Schlitt HJ. The biology of CD45 and its use as a therapeutic target. Leuk Lymphoma. 2004;45:229–36.CrossRefPubMed
9.
go back to reference Marsee DK, Pinkus GS, Yu H. CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens. Am J Clin Pathol. 2010;134:429–35.CrossRefPubMed Marsee DK, Pinkus GS, Yu H. CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens. Am J Clin Pathol. 2010;134:429–35.CrossRefPubMed
10.
go back to reference Nagafuchi A, Shirayoshi Y, Okazaki K, Yasuda K, Takeichi M. Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA. Nature. 1987;329:341–3.CrossRefPubMed Nagafuchi A, Shirayoshi Y, Okazaki K, Yasuda K, Takeichi M. Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA. Nature. 1987;329:341–3.CrossRefPubMed
11.
go back to reference Armeanu S, Müller CA, Klein G. Involvement of E-cadherin in the development of erythroid cells; subject heading. Hematology. 2005;5:307–16.CrossRef Armeanu S, Müller CA, Klein G. Involvement of E-cadherin in the development of erythroid cells; subject heading. Hematology. 2005;5:307–16.CrossRef
12.
go back to reference Armeanu S, Bühring HJ, Reuss-Borst M, Müller CA, Klein G. E-cadherin is functionally involved in the maturation of the erythroid lineage. J Cell Biol. 1995;131:243–9.CrossRefPubMed Armeanu S, Bühring HJ, Reuss-Borst M, Müller CA, Klein G. E-cadherin is functionally involved in the maturation of the erythroid lineage. J Cell Biol. 1995;131:243–9.CrossRefPubMed
13.
go back to reference Villeval JL, Le Van Kim C, Bettajeb A, Debili N, Colin Y, el Maliki B, et al. Early expression of glycophorin C during normal and leukemic human erythroid differentiation. Cancer Res. 1989;49:2626–32.PubMed Villeval JL, Le Van Kim C, Bettajeb A, Debili N, Colin Y, el Maliki B, et al. Early expression of glycophorin C during normal and leukemic human erythroid differentiation. Cancer Res. 1989;49:2626–32.PubMed
14.
go back to reference Domingo-Claros A, Larriba I, Rozman M, Irriquible D, Vallespí T, Aventin A, et al. Acute erythroid neoplastic proliferations. A biological study based on 62 patients. Haematologica. 2002;87:148–53.PubMed Domingo-Claros A, Larriba I, Rozman M, Irriquible D, Vallespí T, Aventin A, et al. Acute erythroid neoplastic proliferations. A biological study based on 62 patients. Haematologica. 2002;87:148–53.PubMed
15.
go back to reference Yamazaki S, Nakamura F, Nasu R, Nannya Y, Ichikawa M, Kurokawa M. Haemophagocytic lymphohistiocytosis is a recurrent and specific complication of acute erythroid leukemia. Br J Haematol. 2011;153:669–72.CrossRefPubMed Yamazaki S, Nakamura F, Nasu R, Nannya Y, Ichikawa M, Kurokawa M. Haemophagocytic lymphohistiocytosis is a recurrent and specific complication of acute erythroid leukemia. Br J Haematol. 2011;153:669–72.CrossRefPubMed
16.
go back to reference Lapadat R, Tower RL 2nd, Tam W, Orazi A, Gheorghe G. Pure erythroid leukemia mimicking ewing sarcoma/primitive neuroectodermal tumor in an infant. Pediatr Blood Cancer. 2016;63:935–7.CrossRefPubMed Lapadat R, Tower RL 2nd, Tam W, Orazi A, Gheorghe G. Pure erythroid leukemia mimicking ewing sarcoma/primitive neuroectodermal tumor in an infant. Pediatr Blood Cancer. 2016;63:935–7.CrossRefPubMed
17.
go back to reference Halliday GC, O’Reilly J, Kelsey C, Cole CH, Kotecha RS. Successful treatment of congenital erythroleukemia with low-dose cytosine arabinoside. Pediatr Blood Cancer. 2016;63:566–7.CrossRefPubMed Halliday GC, O’Reilly J, Kelsey C, Cole CH, Kotecha RS. Successful treatment of congenital erythroleukemia with low-dose cytosine arabinoside. Pediatr Blood Cancer. 2016;63:566–7.CrossRefPubMed
18.
go back to reference Wang HY, Huang LJ, Liu Z, Garcia R, Li S, Galliani CA. Erythroblastic sarcoma presenting as bilateral ovarian masses in an infant with pure erythroid leukemia. Hum Pathol. 2011;42:749–58.CrossRefPubMedPubMedCentral Wang HY, Huang LJ, Liu Z, Garcia R, Li S, Galliani CA. Erythroblastic sarcoma presenting as bilateral ovarian masses in an infant with pure erythroid leukemia. Hum Pathol. 2011;42:749–58.CrossRefPubMedPubMedCentral
19.
go back to reference van Dongen JC, Dalinghaus M, Kroon AA, de Vries AC, van den Heuvel-Eibrink MM. Successful treatment of congenital acute myeloid leukemia (AML-M6) in a premature infant. J Pediatr Hematol Oncol. 2009;31:853–4.CrossRefPubMed van Dongen JC, Dalinghaus M, Kroon AA, de Vries AC, van den Heuvel-Eibrink MM. Successful treatment of congenital acute myeloid leukemia (AML-M6) in a premature infant. J Pediatr Hematol Oncol. 2009;31:853–4.CrossRefPubMed
20.
go back to reference Haught EA, Johnson MC, Witt PD. Congenital erythroleukemia presenting as a congenital infantile hemangioma. Plast Reconstr Surg. 2007;119:70e–2e.CrossRefPubMed Haught EA, Johnson MC, Witt PD. Congenital erythroleukemia presenting as a congenital infantile hemangioma. Plast Reconstr Surg. 2007;119:70e–2e.CrossRefPubMed
21.
go back to reference Mora J, Cruz O, Tuset E, del Mar Perez M. Primitive hematopoietic malignant neoplasm presenting as a CD43-positive, small round, blue-cell tumor in an infant. Pediatr Blood Cancer. 2005;45:865–6.CrossRefPubMed Mora J, Cruz O, Tuset E, del Mar Perez M. Primitive hematopoietic malignant neoplasm presenting as a CD43-positive, small round, blue-cell tumor in an infant. Pediatr Blood Cancer. 2005;45:865–6.CrossRefPubMed
22.
go back to reference Lazure T, Beauchamp A, Croisille L, Ferlicot S, Feneux D, Fabre M. Congenital anerythremic erythroleukemia presenting as hepatic failure. Arch Pathol Lab Med. 2003;127:1362–5.PubMed Lazure T, Beauchamp A, Croisille L, Ferlicot S, Feneux D, Fabre M. Congenital anerythremic erythroleukemia presenting as hepatic failure. Arch Pathol Lab Med. 2003;127:1362–5.PubMed
23.
go back to reference Hadjiyannakis A, Fletcher WA, Lebrun DP, van Wylick RC, Dow KE. Congenital erythroleukemia in a neonate with severe hypoxic ischemic encephalopathy. Am J Perinatol. 1998;15:689–94.CrossRefPubMed Hadjiyannakis A, Fletcher WA, Lebrun DP, van Wylick RC, Dow KE. Congenital erythroleukemia in a neonate with severe hypoxic ischemic encephalopathy. Am J Perinatol. 1998;15:689–94.CrossRefPubMed
24.
go back to reference Allan RR, Wadsworth LD, Kalousek DK, Massing BG. Congenital erythroleukemia: a case report with morphological, immunophenotypic, and cytogenetic findings. Am J Hematol. 1989;31:114–21.CrossRefPubMed Allan RR, Wadsworth LD, Kalousek DK, Massing BG. Congenital erythroleukemia: a case report with morphological, immunophenotypic, and cytogenetic findings. Am J Hematol. 1989;31:114–21.CrossRefPubMed
26.
go back to reference Tamura Tomohiko, Kurotaki Daisuke, Koizumi Shin-ichi. Regulation of myelopoiesis by the transcription factor IRF8. Int J Hematol. 2015;101:342–51.CrossRefPubMed Tamura Tomohiko, Kurotaki Daisuke, Koizumi Shin-ichi. Regulation of myelopoiesis by the transcription factor IRF8. Int J Hematol. 2015;101:342–51.CrossRefPubMed
Metadata
Title
Congenital immature pure erythroid leukemia with E-cadherin expression
Authors
Akihiro Tamura
Suguru Uemura
Atsuro Saito
Saki Okubo
Nanako Nino
Teppei Tahara
Takehito Yokoi
Kenji Kishimoto
Toshiaki Ishida
Daiichiro Hasegawa
Keiichiro Kawasaki
Seiji Yoshimoto
Hideto Nakao
Makiko Yoshida
Yoshiyuki Kosaka
Publication date
01-11-2017
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 5/2017
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-017-2248-7

Other articles of this Issue 5/2017

International Journal of Hematology 5/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine